Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | N,N-Dimethylaminoethyl chloride hydrochloride | HCID 11636816 | — |
| Reactant | HCID 86753899 | HCID 86753899 | — |
| Catalyst | Hexadecyltrimethylammonium Bromide | HCID 5974 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 86753897 | HCID 86753897 | 29% |
Reaction Steps
To a mixture of (2R)-1-[3,5-bis(trifluoromethyl)-benzoyl]-2-(1H-indol-3-yl-methyl)-4-(4-nitro-trans-cinnamoyl)piperazine (100 mg), powdered sodium hydroxide (30 mg) and cetyltrimethylammonium bromide (10 mg) in dichloromethane (2 ml) was added 2-dimethylaminoethyl chloride hydrochloride (50 mg) at room temperature. The resulting mixture was stirred at the same temperature for 14 hours. After adding dichloromethane (10 ml), the reaction mixture was filtered through Celite pad and the filtrate was concentrated in vacuo. The resulting residue was purified by column chromatography on a silica gel eluting with a mixture of dichloromethane and methanol (30:1) and then treated with 4N hydrogen chloride in ethyl acetate solution to give (2R)-1-[3,5-bis(-trifluoromethyl)benzoyl]-2-[1-(2-dimethylaminoethyl)-1H-indol-3-yl-methyl]-4-(4-nitro-trans-cinnamoyl)piperazine hydrochloride (34 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05883098 |
|---|
| Source dataset | uspto-grants-1999_03 |
|---|
| ORD ID | ord-ef7a2cf7c14f4fab9d7c87f23a1a9ac5 |
|---|
| Source note | uspto-grants-1999_03 |
|---|